-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology: What are the unique features of in vitro assay platforms?
Author:
InnoModels
Release time:
2024-03-28
In the field of biomedicine, in vitro assay platforms, as an important tool for research, drug development and clinical diagnosis, are increasingly showing their unique value and advantages. With its excellent technical performance, wide range of applications and efficient experimental process, the in vitro assay platform of InnoModels Biotechnology is gradually becoming a leader in the industry.
1、Leading technology, accurate and reliable
InnoModels' in vitro assay platform adopts advanced biotechnology and molecular biology methods to ensure the accuracy and reliability of the experimental results. The platform covers gene expression analysis, protein interaction, drug screening and other aspects, providing researchers with comprehensive and efficient experimental means.
2、Wide range of applications to meet diversified needs
InnoModels' in vitro assay platform can be applied to drug discovery, disease diagnosis, biomarker discovery and other fields. By simulating the physiological environment in the human body, the platform can accurately reflect the interaction between drugs and biomolecules, providing strong support for drug development. At the same time, the platform can also provide rapid and accurate test results for disease diagnosis, providing a scientific basis for clinical decision-making.
3. Optimization of experimental process to improve efficiency
InnoModels Biotechnology in vitro assay platform focuses on the optimization and integration of the experimental process, and greatly improves the experimental efficiency through automated and standardized experimental operations. At the same time, the platform also provides a perfect experimental data management and analysis system to help researchers quickly obtain experimental results and shorten the research cycle.

4、Personalized services to meet different customer needs
InnoModels Biotechnology in vitro testing platform also provides personalized services, customized experimental solutions and technical support according to customer needs. The platform has a professional technical team and a perfect customer service system to ensure that customers get timely and professional help in the process of use.
5、Continuous innovation, leading the development of the industry
InnoModels' in vitro testing platform has always maintained its focus on and exploration of new technologies and methods, and has continuously introduced new experimental technologies and methods to meet the needs of the industry's development. At the same time, the platform also actively participates in academic exchanges and cooperation at home and abroad to promote the continuous innovation and development of in vitro testing technology.
In conclusion, with its advantages of leading technology, wide range of application fields, optimized experimental process, personalized service and continuous innovation, InnoModels' in vitro assay platform provides strong support for the research and development of the biomedical field. In the future, with the continuous progress and innovation of science and technology, we have reason to believe that the InnoModels Biotechnology in vitro assay platform will play an even more important role in the exploration of life sciences.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd